Author

John K. Yoon

Observed names: John K Yoon, John Yoon

Observed institutions: Tufts University, Cleveland Clinic, Dana-Farber Cancer Institute

ORCID: 0000-0003-4965-3902

Observed ORCID: 0000-0003-4965-3902

OpenAlex ID: A5068937669

An Anti-HIV-1 V3 Loop Antibody Fully Protects Cross-Clade and Elicits T-Cell Immunity in Macaques Mucosally Challenged with an R5 Clade C SHIV

2011 · Jennifer D. Watkins, Nagadenahalli B. Siddappa, et al. · PLoS ONE · 81

Gene Therapy Developments for Pompe Disease

2022 · Zeenath Unnisa, John K. Yoon, et al. · Biomedicines · 53

Prime–boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: Efficacy against repeated mucosal R5 clade C SHIV challenges

2011 · Samir K. Lakhashe, Vijayakumar Velu, et al. · Vaccine · 42

Vaccination against Heterologous R5 Clade C SHIV: Prevention of Infection and Correlates of Protection

2011 · Samir K. Lakhashe, Wendy Wang, et al. · PLoS ONE · 25

FDG Positron Emission Tomography/Computerized Tomography Features of Bleomycin-induced Pneumonitis

2006 · Jacobo Kirsch, Andrea V. Arrossi, et al. · Journal of Thoracic Imaging · 24

HIV proviral DNA integration can drive T cell growth ex vivo

2020 · John K. Yoon, Joseph R. Holloway, et al. · Proceedings of the National Academy of Sciences · 19

Screening chimeric GAA variants in preclinical study results in hematopoietic stem cell gene therapy candidate vectors for Pompe disease

2022 · Yildirim Dogan, Cecilia N. Barese, et al. · Molecular Therapy — Methods & Clinical Development · 17

Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose

2014 · Anton M Sholukh, Siddappa N Byrareddy, et al. · Retrovirology · 16

High-throughput analysis of hematopoietic stem cell engraftment after intravenous and intracerebroventricular dosing

2022 · Robert N. Plasschaert, Mark P. DeAndrade, et al. · Molecular Therapy · 12

Preclinical lentiviral hematopoietic stem cell gene therapy corrects Pompe disease-related muscle and neurological manifestations

2024 · John K. Yoon, Jeffrey W. Schindler, et al. · Molecular Therapy · 7

Long-term hematopoietic stem cell lentiviral gene therapy rescues neuromuscular manifestations in preclinical study of Pompe disease mice

2022 · Niek P. van Til, Jeffrey W. Schindler, et al. · Molecular Genetics and Metabolism

Long-term hematopoietic stem cell gene therapy corrects neuromuscular manifestations in preclinical study of Pompe mice

2021 · Niek P. van Til, Yildirim Dogan, et al. · Molecular Genetics and Metabolism

Works count: 12

Citation count: 296

H-index: 9

I10-index: 9